nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Headache—Vinblastine—kidney cancer	0.000741	0.000741	CcSEcCtD
Perflutren—Angioedema—Paclitaxel—kidney cancer	0.00074	0.00074	CcSEcCtD
Perflutren—Headache—Everolimus—kidney cancer	0.000738	0.000738	CcSEcCtD
Perflutren—Hypotension—Gemcitabine—kidney cancer	0.000737	0.000737	CcSEcCtD
Perflutren—Abdominal pain—Dactinomycin—kidney cancer	0.000736	0.000736	CcSEcCtD
Perflutren—Body temperature increased—Dactinomycin—kidney cancer	0.000736	0.000736	CcSEcCtD
Perflutren—Visual impairment—Capecitabine—kidney cancer	0.000735	0.000735	CcSEcCtD
Perflutren—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000735	0.000735	CcSEcCtD
Perflutren—Asthenia—Sorafenib—kidney cancer	0.000733	0.000733	CcSEcCtD
Perflutren—Malaise—Paclitaxel—kidney cancer	0.00073	0.00073	CcSEcCtD
Perflutren—Vertigo—Paclitaxel—kidney cancer	0.000727	0.000727	CcSEcCtD
Perflutren—Syncope—Paclitaxel—kidney cancer	0.000726	0.000726	CcSEcCtD
Perflutren—Leukopenia—Paclitaxel—kidney cancer	0.000725	0.000725	CcSEcCtD
Perflutren—Hypersensitivity—Sunitinib—kidney cancer	0.000725	0.000725	CcSEcCtD
Perflutren—Pruritus—Sorafenib—kidney cancer	0.000723	0.000723	CcSEcCtD
Perflutren—Vomiting—Erlotinib—kidney cancer	0.000722	0.000722	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000719	0.000719	CcSEcCtD
Perflutren—Gastrointestinal disorder—Vincristine—kidney cancer	0.000718	0.000718	CcSEcCtD
Perflutren—Fatigue—Vincristine—kidney cancer	0.000717	0.000717	CcSEcCtD
Perflutren—Rash—Erlotinib—kidney cancer	0.000716	0.000716	CcSEcCtD
Perflutren—Dermatitis—Erlotinib—kidney cancer	0.000716	0.000716	CcSEcCtD
Perflutren—Palpitations—Paclitaxel—kidney cancer	0.000715	0.000715	CcSEcCtD
Perflutren—Eye disorder—Capecitabine—kidney cancer	0.000713	0.000713	CcSEcCtD
Perflutren—Headache—Erlotinib—kidney cancer	0.000712	0.000712	CcSEcCtD
Perflutren—Tinnitus—Capecitabine—kidney cancer	0.000712	0.000712	CcSEcCtD
Perflutren—Loss of consciousness—Paclitaxel—kidney cancer	0.000712	0.000712	CcSEcCtD
Perflutren—Pain—Vincristine—kidney cancer	0.000711	0.000711	CcSEcCtD
Perflutren—Paraesthesia—Gemcitabine—kidney cancer	0.000709	0.000709	CcSEcCtD
Perflutren—Cardiac disorder—Capecitabine—kidney cancer	0.000708	0.000708	CcSEcCtD
Perflutren—Flushing—Capecitabine—kidney cancer	0.000708	0.000708	CcSEcCtD
Perflutren—Cough—Paclitaxel—kidney cancer	0.000706	0.000706	CcSEcCtD
Perflutren—Asthenia—Sunitinib—kidney cancer	0.000706	0.000706	CcSEcCtD
Perflutren—Dyspnoea—Gemcitabine—kidney cancer	0.000704	0.000704	CcSEcCtD
Perflutren—Nausea—Vinblastine—kidney cancer	0.000702	0.000702	CcSEcCtD
Perflutren—Convulsion—Paclitaxel—kidney cancer	0.000701	0.000701	CcSEcCtD
Perflutren—Nausea—Everolimus—kidney cancer	0.000699	0.000699	CcSEcCtD
Perflutren—Diarrhoea—Sorafenib—kidney cancer	0.000699	0.000699	CcSEcCtD
Perflutren—Hypertension—Paclitaxel—kidney cancer	0.000699	0.000699	CcSEcCtD
Perflutren—Pruritus—Sunitinib—kidney cancer	0.000696	0.000696	CcSEcCtD
Perflutren—Angiopathy—Capecitabine—kidney cancer	0.000692	0.000692	CcSEcCtD
Perflutren—Immune system disorder—Capecitabine—kidney cancer	0.000689	0.000689	CcSEcCtD
Perflutren—Myalgia—Paclitaxel—kidney cancer	0.000689	0.000689	CcSEcCtD
Perflutren—Chest pain—Paclitaxel—kidney cancer	0.000689	0.000689	CcSEcCtD
Perflutren—Arthralgia—Paclitaxel—kidney cancer	0.000689	0.000689	CcSEcCtD
Perflutren—Mediastinal disorder—Capecitabine—kidney cancer	0.000688	0.000688	CcSEcCtD
Perflutren—Face oedema—Doxorubicin—kidney cancer	0.000687	0.000687	CcSEcCtD
Perflutren—Hypersensitivity—Dactinomycin—kidney cancer	0.000686	0.000686	CcSEcCtD
Perflutren—Chills—Capecitabine—kidney cancer	0.000685	0.000685	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000684	0.000684	CcSEcCtD
Perflutren—Arrhythmia—Capecitabine—kidney cancer	0.000682	0.000682	CcSEcCtD
Perflutren—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000681	0.000681	CcSEcCtD
Perflutren—Discomfort—Paclitaxel—kidney cancer	0.000681	0.000681	CcSEcCtD
Perflutren—Fatigue—Gemcitabine—kidney cancer	0.00068	0.00068	CcSEcCtD
Perflutren—Gastrointestinal pain—Vincristine—kidney cancer	0.00068	0.00068	CcSEcCtD
Perflutren—Cardiac arrest—Doxorubicin—kidney cancer	0.000676	0.000676	CcSEcCtD
Perflutren—Dizziness—Sorafenib—kidney cancer	0.000676	0.000676	CcSEcCtD
Perflutren—Pain—Gemcitabine—kidney cancer	0.000675	0.000675	CcSEcCtD
Perflutren—Nausea—Erlotinib—kidney cancer	0.000675	0.000675	CcSEcCtD
Perflutren—Dry mouth—Paclitaxel—kidney cancer	0.000674	0.000674	CcSEcCtD
Perflutren—Diarrhoea—Sunitinib—kidney cancer	0.000673	0.000673	CcSEcCtD
Perflutren—Asthenia—Dactinomycin—kidney cancer	0.000668	0.000668	CcSEcCtD
Perflutren—Erythema—Capecitabine—kidney cancer	0.000664	0.000664	CcSEcCtD
Perflutren—Anaphylactic shock—Paclitaxel—kidney cancer	0.000661	0.000661	CcSEcCtD
Perflutren—Oedema—Paclitaxel—kidney cancer	0.000661	0.000661	CcSEcCtD
Perflutren—Abdominal pain—Vincristine—kidney cancer	0.000658	0.000658	CcSEcCtD
Perflutren—Body temperature increased—Vincristine—kidney cancer	0.000658	0.000658	CcSEcCtD
Perflutren—Dry skin—Doxorubicin—kidney cancer	0.000652	0.000652	CcSEcCtD
Perflutren—Dysgeusia—Capecitabine—kidney cancer	0.000651	0.000651	CcSEcCtD
Perflutren—Dizziness—Sunitinib—kidney cancer	0.00065	0.00065	CcSEcCtD
Perflutren—Feeling abnormal—Gemcitabine—kidney cancer	0.00065	0.00065	CcSEcCtD
Perflutren—Shock—Paclitaxel—kidney cancer	0.00065	0.00065	CcSEcCtD
Perflutren—Vomiting—Sorafenib—kidney cancer	0.00065	0.00065	CcSEcCtD
Perflutren—Nervous system disorder—Paclitaxel—kidney cancer	0.000648	0.000648	CcSEcCtD
Perflutren—Tachycardia—Paclitaxel—kidney cancer	0.000645	0.000645	CcSEcCtD
Perflutren—Rash—Sorafenib—kidney cancer	0.000644	0.000644	CcSEcCtD
Perflutren—Dermatitis—Sorafenib—kidney cancer	0.000644	0.000644	CcSEcCtD
Perflutren—Back pain—Capecitabine—kidney cancer	0.000643	0.000643	CcSEcCtD
Perflutren—Skin disorder—Paclitaxel—kidney cancer	0.000642	0.000642	CcSEcCtD
Perflutren—Headache—Sorafenib—kidney cancer	0.00064	0.00064	CcSEcCtD
Perflutren—Muscle spasms—Capecitabine—kidney cancer	0.000639	0.000639	CcSEcCtD
Perflutren—Hyperhidrosis—Paclitaxel—kidney cancer	0.000639	0.000639	CcSEcCtD
Perflutren—Diarrhoea—Dactinomycin—kidney cancer	0.000637	0.000637	CcSEcCtD
Perflutren—Vision blurred—Capecitabine—kidney cancer	0.000626	0.000626	CcSEcCtD
Perflutren—Vomiting—Sunitinib—kidney cancer	0.000625	0.000625	CcSEcCtD
Perflutren—Body temperature increased—Gemcitabine—kidney cancer	0.000624	0.000624	CcSEcCtD
Perflutren—Tremor—Capecitabine—kidney cancer	0.000622	0.000622	CcSEcCtD
Perflutren—Rash—Sunitinib—kidney cancer	0.00062	0.00062	CcSEcCtD
Perflutren—Dermatitis—Sunitinib—kidney cancer	0.00062	0.00062	CcSEcCtD
Perflutren—Hypotension—Paclitaxel—kidney cancer	0.000617	0.000617	CcSEcCtD
Perflutren—Ill-defined disorder—Capecitabine—kidney cancer	0.000616	0.000616	CcSEcCtD
Perflutren—Headache—Sunitinib—kidney cancer	0.000616	0.000616	CcSEcCtD
Perflutren—Hypersensitivity—Vincristine—kidney cancer	0.000613	0.000613	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—kidney cancer	0.000609	0.000609	CcSEcCtD
Perflutren—Nausea—Sorafenib—kidney cancer	0.000607	0.000607	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000602	0.000602	CcSEcCtD
Perflutren—Malaise—Capecitabine—kidney cancer	0.000599	0.000599	CcSEcCtD
Perflutren—Vertigo—Capecitabine—kidney cancer	0.000597	0.000597	CcSEcCtD
Perflutren—Asthenia—Vincristine—kidney cancer	0.000597	0.000597	CcSEcCtD
Perflutren—Syncope—Capecitabine—kidney cancer	0.000596	0.000596	CcSEcCtD
Perflutren—Leukopenia—Capecitabine—kidney cancer	0.000595	0.000595	CcSEcCtD
Perflutren—Paraesthesia—Paclitaxel—kidney cancer	0.000593	0.000593	CcSEcCtD
Perflutren—Vomiting—Dactinomycin—kidney cancer	0.000592	0.000592	CcSEcCtD
Perflutren—Dyspnoea—Paclitaxel—kidney cancer	0.000589	0.000589	CcSEcCtD
Perflutren—Palpitations—Capecitabine—kidney cancer	0.000587	0.000587	CcSEcCtD
Perflutren—Rash—Dactinomycin—kidney cancer	0.000587	0.000587	CcSEcCtD
Perflutren—Nausea—Sunitinib—kidney cancer	0.000584	0.000584	CcSEcCtD
Perflutren—Loss of consciousness—Capecitabine—kidney cancer	0.000584	0.000584	CcSEcCtD
Perflutren—Dyspepsia—Paclitaxel—kidney cancer	0.000582	0.000582	CcSEcCtD
Perflutren—Cough—Capecitabine—kidney cancer	0.00058	0.00058	CcSEcCtD
Perflutren—Hypertension—Capecitabine—kidney cancer	0.000574	0.000574	CcSEcCtD
Perflutren—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00057	0.00057	CcSEcCtD
Perflutren—Fatigue—Paclitaxel—kidney cancer	0.00057	0.00057	CcSEcCtD
Perflutren—Diarrhoea—Vincristine—kidney cancer	0.000569	0.000569	CcSEcCtD
Perflutren—Asthenia—Gemcitabine—kidney cancer	0.000566	0.000566	CcSEcCtD
Perflutren—Myalgia—Capecitabine—kidney cancer	0.000566	0.000566	CcSEcCtD
Perflutren—Chest pain—Capecitabine—kidney cancer	0.000566	0.000566	CcSEcCtD
Perflutren—Arthralgia—Capecitabine—kidney cancer	0.000566	0.000566	CcSEcCtD
Perflutren—Pain—Paclitaxel—kidney cancer	0.000565	0.000565	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000562	0.000562	CcSEcCtD
Perflutren—Discomfort—Capecitabine—kidney cancer	0.000559	0.000559	CcSEcCtD
Perflutren—Pruritus—Gemcitabine—kidney cancer	0.000558	0.000558	CcSEcCtD
Perflutren—Dry mouth—Capecitabine—kidney cancer	0.000553	0.000553	CcSEcCtD
Perflutren—Nausea—Dactinomycin—kidney cancer	0.000553	0.000553	CcSEcCtD
Perflutren—Dizziness—Vincristine—kidney cancer	0.00055	0.00055	CcSEcCtD
Perflutren—Feeling abnormal—Paclitaxel—kidney cancer	0.000544	0.000544	CcSEcCtD
Perflutren—Oedema—Capecitabine—kidney cancer	0.000542	0.000542	CcSEcCtD
Perflutren—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00054	0.00054	CcSEcCtD
Perflutren—Diarrhoea—Gemcitabine—kidney cancer	0.00054	0.00054	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000537	0.000537	CcSEcCtD
Perflutren—Shock—Capecitabine—kidney cancer	0.000533	0.000533	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—kidney cancer	0.000533	0.000533	CcSEcCtD
Perflutren—Nervous system disorder—Capecitabine—kidney cancer	0.000532	0.000532	CcSEcCtD
Perflutren—Tachycardia—Capecitabine—kidney cancer	0.000529	0.000529	CcSEcCtD
Perflutren—Vomiting—Vincristine—kidney cancer	0.000529	0.000529	CcSEcCtD
Perflutren—Skin disorder—Capecitabine—kidney cancer	0.000527	0.000527	CcSEcCtD
Perflutren—Urticaria—Paclitaxel—kidney cancer	0.000525	0.000525	CcSEcCtD
Perflutren—Rash—Vincristine—kidney cancer	0.000525	0.000525	CcSEcCtD
Perflutren—Hyperhidrosis—Capecitabine—kidney cancer	0.000524	0.000524	CcSEcCtD
Perflutren—Dermatitis—Vincristine—kidney cancer	0.000524	0.000524	CcSEcCtD
Perflutren—Body temperature increased—Paclitaxel—kidney cancer	0.000522	0.000522	CcSEcCtD
Perflutren—Abdominal pain—Paclitaxel—kidney cancer	0.000522	0.000522	CcSEcCtD
Perflutren—Headache—Vincristine—kidney cancer	0.000521	0.000521	CcSEcCtD
Perflutren—Hypotension—Capecitabine—kidney cancer	0.000507	0.000507	CcSEcCtD
Perflutren—Vomiting—Gemcitabine—kidney cancer	0.000502	0.000502	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—kidney cancer	0.000501	0.000501	CcSEcCtD
Perflutren—Rash—Gemcitabine—kidney cancer	0.000498	0.000498	CcSEcCtD
Perflutren—Dermatitis—Gemcitabine—kidney cancer	0.000497	0.000497	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—kidney cancer	0.000494	0.000494	CcSEcCtD
Perflutren—Headache—Gemcitabine—kidney cancer	0.000494	0.000494	CcSEcCtD
Perflutren—Nausea—Vincristine—kidney cancer	0.000494	0.000494	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000494	0.000494	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—kidney cancer	0.000493	0.000493	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—kidney cancer	0.000492	0.000492	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—kidney cancer	0.000489	0.000489	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—kidney cancer	0.000488	0.000488	CcSEcCtD
Perflutren—Paraesthesia—Capecitabine—kidney cancer	0.000487	0.000487	CcSEcCtD
Perflutren—Hypersensitivity—Paclitaxel—kidney cancer	0.000487	0.000487	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—kidney cancer	0.000483	0.000483	CcSEcCtD
Perflutren—Dyspnoea—Capecitabine—kidney cancer	0.000483	0.000483	CcSEcCtD
Perflutren—Dyspepsia—Capecitabine—kidney cancer	0.000477	0.000477	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—kidney cancer	0.000474	0.000474	CcSEcCtD
Perflutren—Asthenia—Paclitaxel—kidney cancer	0.000474	0.000474	CcSEcCtD
Perflutren—Nausea—Gemcitabine—kidney cancer	0.000469	0.000469	CcSEcCtD
Perflutren—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000468	0.000468	CcSEcCtD
Perflutren—Fatigue—Capecitabine—kidney cancer	0.000467	0.000467	CcSEcCtD
Perflutren—Pruritus—Paclitaxel—kidney cancer	0.000467	0.000467	CcSEcCtD
Perflutren—Pain—Capecitabine—kidney cancer	0.000464	0.000464	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—kidney cancer	0.00046	0.00046	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—kidney cancer	0.000459	0.000459	CcSEcCtD
Perflutren—Flushing—Doxorubicin—kidney cancer	0.000457	0.000457	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—kidney cancer	0.000457	0.000457	CcSEcCtD
Perflutren—Diarrhoea—Paclitaxel—kidney cancer	0.000452	0.000452	CcSEcCtD
Perflutren—Feeling abnormal—Capecitabine—kidney cancer	0.000447	0.000447	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—kidney cancer	0.000446	0.000446	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—kidney cancer	0.000444	0.000444	CcSEcCtD
Perflutren—Gastrointestinal pain—Capecitabine—kidney cancer	0.000443	0.000443	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—kidney cancer	0.000443	0.000443	CcSEcCtD
Perflutren—Chills—Doxorubicin—kidney cancer	0.000441	0.000441	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—kidney cancer	0.000439	0.000439	CcSEcCtD
Perflutren—Dizziness—Paclitaxel—kidney cancer	0.000437	0.000437	CcSEcCtD
Perflutren—Urticaria—Capecitabine—kidney cancer	0.000431	0.000431	CcSEcCtD
Perflutren—Abdominal pain—Capecitabine—kidney cancer	0.000429	0.000429	CcSEcCtD
Perflutren—Body temperature increased—Capecitabine—kidney cancer	0.000429	0.000429	CcSEcCtD
Perflutren—Erythema—Doxorubicin—kidney cancer	0.000428	0.000428	CcSEcCtD
Perflutren—Vomiting—Paclitaxel—kidney cancer	0.00042	0.00042	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—kidney cancer	0.000419	0.000419	CcSEcCtD
Perflutren—Rash—Paclitaxel—kidney cancer	0.000417	0.000417	CcSEcCtD
Perflutren—Dermatitis—Paclitaxel—kidney cancer	0.000416	0.000416	CcSEcCtD
Perflutren—Back pain—Doxorubicin—kidney cancer	0.000414	0.000414	CcSEcCtD
Perflutren—Headache—Paclitaxel—kidney cancer	0.000414	0.000414	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—kidney cancer	0.000412	0.000412	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—kidney cancer	0.000404	0.000404	CcSEcCtD
Perflutren—Hypersensitivity—Capecitabine—kidney cancer	0.000399	0.000399	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—kidney cancer	0.000397	0.000397	CcSEcCtD
Perflutren—Agitation—Doxorubicin—kidney cancer	0.000394	0.000394	CcSEcCtD
Perflutren—Nausea—Paclitaxel—kidney cancer	0.000392	0.000392	CcSEcCtD
Perflutren—Asthenia—Capecitabine—kidney cancer	0.000389	0.000389	CcSEcCtD
Perflutren—Malaise—Doxorubicin—kidney cancer	0.000386	0.000386	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—kidney cancer	0.000385	0.000385	CcSEcCtD
Perflutren—Syncope—Doxorubicin—kidney cancer	0.000384	0.000384	CcSEcCtD
Perflutren—Pruritus—Capecitabine—kidney cancer	0.000384	0.000384	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—kidney cancer	0.000383	0.000383	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—kidney cancer	0.000378	0.000378	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—kidney cancer	0.000376	0.000376	CcSEcCtD
Perflutren—Cough—Doxorubicin—kidney cancer	0.000374	0.000374	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—kidney cancer	0.000371	0.000371	CcSEcCtD
Perflutren—Diarrhoea—Capecitabine—kidney cancer	0.000371	0.000371	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—kidney cancer	0.00037	0.00037	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—kidney cancer	0.000365	0.000365	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—kidney cancer	0.000365	0.000365	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—kidney cancer	0.000365	0.000365	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000362	0.000362	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—kidney cancer	0.00036	0.00036	CcSEcCtD
Perflutren—Dizziness—Capecitabine—kidney cancer	0.000359	0.000359	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—kidney cancer	0.000357	0.000357	CcSEcCtD
Perflutren—Oedema—Doxorubicin—kidney cancer	0.00035	0.00035	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—kidney cancer	0.00035	0.00035	CcSEcCtD
Perflutren—Vomiting—Capecitabine—kidney cancer	0.000345	0.000345	CcSEcCtD
Perflutren—Shock—Doxorubicin—kidney cancer	0.000344	0.000344	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—kidney cancer	0.000343	0.000343	CcSEcCtD
Perflutren—Rash—Capecitabine—kidney cancer	0.000342	0.000342	CcSEcCtD
Perflutren—Dermatitis—Capecitabine—kidney cancer	0.000342	0.000342	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—kidney cancer	0.000341	0.000341	CcSEcCtD
Perflutren—Headache—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—kidney cancer	0.000339	0.000339	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—kidney cancer	0.000338	0.000338	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—kidney cancer	0.000327	0.000327	CcSEcCtD
Perflutren—Nausea—Capecitabine—kidney cancer	0.000322	0.000322	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000318	0.000318	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—kidney cancer	0.000314	0.000314	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—kidney cancer	0.000312	0.000312	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—kidney cancer	0.000308	0.000308	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000302	0.000302	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—kidney cancer	0.000301	0.000301	CcSEcCtD
Perflutren—Pain—Doxorubicin—kidney cancer	0.000299	0.000299	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—kidney cancer	0.000288	0.000288	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000286	0.000286	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—kidney cancer	0.000278	0.000278	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—kidney cancer	0.000276	0.000276	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—kidney cancer	0.000276	0.000276	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—kidney cancer	0.000258	0.000258	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—kidney cancer	0.000251	0.000251	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—kidney cancer	0.000247	0.000247	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—kidney cancer	0.000239	0.000239	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—kidney cancer	0.000231	0.000231	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—kidney cancer	0.000222	0.000222	CcSEcCtD
Perflutren—Rash—Doxorubicin—kidney cancer	0.00022	0.00022	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—kidney cancer	0.00022	0.00022	CcSEcCtD
Perflutren—Headache—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Perflutren—Nausea—Doxorubicin—kidney cancer	0.000208	0.000208	CcSEcCtD
